Clinical Trial Update: Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating Leflunomide for neuroendocrine tumors associated with multiple endocrine neoplasia type 1; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Endocrine Neoplasia Type
• Neuroendocrine Tumor

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Neuroendocrine Tumors | Phase 2 | Status: RECRUITING